XBIO (STOCKS)
Xenetic Biosciences, Inc.
$3.110000
+0.050000 (+1.63%)
Prev close: $3.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- James F. Parslow
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.11M
- Employees
- 2
- P/E (TTM)
- -1.92
- P/B (TTM)
- 0.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.98M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $5.81M |
| Nonoperating Income/Loss | $153.72K |
| Operating Expenses | $5.81M |
| Research and Development | $3.07M |
| Other Operating Expenses | $2.75M |
| Operating Income/Loss | -$2.83M |
| Income/Loss From Continuing Operations After Tax | -$2.68M |
| Income/Loss From Continuing Operations Before Tax | $2.98M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Income/Expense After Provision For Losses | $148.00K |
| Interest Income/Expense Operating, Net | $148.00K |
| Net Income/Loss | -$2.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.58 |
| Diluted Earnings Per Share | -$1.58 |
| Basic Average Shares | 1,701,571 |
| Diluted Average Shares | 1,701,571 |
| Assets | $8.36M |
| Current Assets | $8.05M |
| Noncurrent Assets | $313.92K |
| Liabilities | $968.03K |
| Current Liabilities | $968.03K |
| Accounts Payable | $258.11K |
| Wages | $84.48K |
| Other Current Liabilities | $625.44K |
| Noncurrent Liabilities | $0.00 |
| Equity | $7.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.40M |
| Liabilities And Equity | $8.36M |
| Net Cash Flow From Operating Activities | -$2.29M |
| Net Cash Flow From Operating Activities, Continuing | -$2.29M |
| Net Cash Flow From Investing Activities | -$1.72M |
| Net Cash Flow From Investing Activities, Continuing | -$1.72M |
| Net Cash Flow From Financing Activities | $4.00M |
| Net Cash Flow From Financing Activities, Continuing | $4.00M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$2.68M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.68M |
| Other Comprehensive Income/Loss | $0.00 |